These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
139 related items for PubMed ID: 19169622
1. Long-term experience with continuous duodenal levodopa-carbidopa infusion (Duodopa): report of six patients. Raudino F, Garavaglia P, Pianezzola C, Riboldazzi G, Leva S, Guidotti M, Bono G. Neurol Sci; 2009 Feb; 30(1):85-6. PubMed ID: 19169622 [No Abstract] [Full Text] [Related]
3. Knotting of Duodopa® duodenal infusion system. del-Hoyo-Francisco J, Bustamante-Balén M, Martínez-Torres I, Barrios-Barrios A, Satorres-Paniagua C, Pons-Beltrán V. Rev Esp Enferm Dig; 2015 May; 107(5):323-4. PubMed ID: 25952811 [No Abstract] [Full Text] [Related]
4. A pharmacokinetic-pharmacodynamic model for duodenal levodopa infusion. Westin J, Nyholm D, Pålhagen S, Willows T, Groth T, Dougherty M, Karlsson MO. Clin Neuropharmacol; 2011 May; 34(2):61-5. PubMed ID: 21297456 [Abstract] [Full Text] [Related]
5. Long-term duodenal levodopa infusion in Parkinson's disease: a 3-year motor and cognitive follow-up study. Zibetti M, Merola A, Ricchi V, Marchisio A, Artusi CA, Rizzi L, Montanaro E, Reggio D, De Angelis C, Rizzone M, Lopiano L. J Neurol; 2013 Jan; 260(1):105-14. PubMed ID: 22772358 [Abstract] [Full Text] [Related]
8. Continuous dopaminergic stimulation achieved by duodenal levodopa infusion. Odin P, Wolters E, Antonini A. Neurol Sci; 2008 Dec; 29 Suppl 5():S387-8. PubMed ID: 19381770 [Abstract] [Full Text] [Related]
9. Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease. Nyholm D, Nilsson Remahl AI, Dizdar N, Constantinescu R, Holmberg B, Jansson R, Aquilonius SM, Askmark H. Neurology; 2005 Jan 25; 64(2):216-23. PubMed ID: 15668416 [Abstract] [Full Text] [Related]
10. Continuous duodenal infusions of levodopa. Fowler SB, Bergen M. J Neurosci Nurs; 1993 Oct 25; 25(5):317-20. PubMed ID: 8270813 [Abstract] [Full Text] [Related]
11. Effect of levodopa-carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients. Antonini A, Fung VS, Boyd JT, Slevin JT, Hall C, Chatamra K, Eaton S, Benesh JA. Mov Disord; 2016 Apr 25; 31(4):530-7. PubMed ID: 26817533 [Abstract] [Full Text] [Related]
12. Dopamine dysregulation syndrome and punding in levodopa-carbidopa intestinal gel (LCIG) infusion: A serious but preventable complication. Salomone G, Marano M, di Biase L, Melgari JM, Di Lazzaro V. Parkinsonism Relat Disord; 2015 Sep 25; 21(9):1124-5. PubMed ID: 26242552 [No Abstract] [Full Text] [Related]
13. Long-term response to continuous duodenal infusion of levodopa/carbidopa gel in patients with advanced Parkinson disease: The Barcelona registry. Buongiorno M, Antonelli F, Cámara A, Puente V, de Fabregues-Nebot O, Hernandez-Vara J, Calopa M, Pascual-Sedano B, Campolongo A, Valldeoriola F, Tolosa E, Kulisevsky J, Martí MJ. Parkinsonism Relat Disord; 2015 Aug 25; 21(8):871-6. PubMed ID: 26003410 [Abstract] [Full Text] [Related]
14. Continuous duodenal levodopa infusion in a patient with Crohn's disease and small bowel surgery - Case report. Tomic S, Skelac D, Mick D, Segec I, Resan B, Soldo SB. J Neurol Sci; 2015 Nov 15; 358(1-2):525-6. PubMed ID: 26443281 [No Abstract] [Full Text] [Related]
15. Transcutaneous port for continuous duodenal levodopa/carbidopa administration in Parkinson's disease. Meppelink AM, Nyman R, van Laar T, Drent M, Prins T, Leenders KL. Mov Disord; 2011 Feb 01; 26(2):331-4. PubMed ID: 20960486 [Abstract] [Full Text] [Related]
16. Long-term intraduodenal infusion of a water based levodopa-carbidopa dispersion in very advanced Parkinson's disease. Nilsson D, Hansson LE, Johansson K, Nyström C, Paalzow L, Aquilonius SM. Acta Neurol Scand; 1998 Mar 01; 97(3):175-83. PubMed ID: 9531434 [Abstract] [Full Text] [Related]